Dr Kerstin Kleinschmidt-Doerr | Could R399E Become a Potential Treatment for Restoring Joints and Relieving Pain in Osteoarthritis?
About this episode
Osteoarthritis is a painful and debilitating condition that affects hundreds of millions of people. The condition significantly affects a patient’s mobility, sleep, and ability to work, ultimately impacting their quality of life and mental health. Treatments involve exercise or medication to reduce pain, but they don’t target underlying structural problems in the joints. Additionally, these treatments do not slow or stop the progression of the disease, and may have serious side-effects on organs such as the liver, kidneys or heart. The search for a treatment that can reduce osteoarthritis pain and treat the affected joint structures remains a ‘substantial unmet medical need’. Read More
Original Article Reference
Summary of the paper ‘R399E, A Mutated Form of Growth and Differentiation Factor 5, for Disease Modification of Osteoarthritis’, in Arthritis & Rheumatology, doi.org/10.1002/art.42343
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.